# catalytic_activity_0144: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/catalytic_activity_0144.txt)

**Task:** `catalytic_activity`  
**Author key, unchanged:** **B** — inosine(in) = inosine(out)

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MTTSSDSAMVNHTPSPWYKFGFKSFAEFNTYVTFVFLGMSIMMVASAVTSAPDFLTRYYVYATGDPDAVAETPLFWNNANTFYNAGTYVLQVLTELFSLTPFMRRIPLSVRLFVGLGIPFAELLLIIIVPAATIKSQHGAIAVIMVVACVGGFSKALCDSCTNALVGPFPTKFMNGAQWGLTVIALLMSIIQIILKVSMGTSFHDILTMSRIYFGICIGIQLFAIFELAILRFNPFAQKYIAEYRAGAQRNAQNNESTLEETAPSMNEPAAGDIADLPATVDDKERALNEEEGDEVRAVTSEEFHVKRGAVLTATGDADKMVDLDQTGNITSTEQLLRASAASVFKRVYPMLVCVFLIYFTSLLTFPGVFFLVSTTSGWYMTVIVTLFNAGDFISRMVLMFRPLRPSPKVVVAGTLGRLIIIPFLVLCVRGIIRGEALPYVLITLLGLTNGYFGCMACIHCPRTTTLRYAGERSLAAMLSGISIMLGLCFGSNLSLAITLTH

[Multiple Choices]
A. lipid A (E. coli) + a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + H(+) = lipid A 4'-(2-aminoethyl diphosphate) (E. coli) + a 1,2-diacyl-sn-glycerol
B. inosine(in) = inosine(out)
C. Mg(2+)(in) = Mg(2+)(out)
D. a primary alcohol + NAD(+) = an aldehyde + NADH + H(+)
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzymatic Reaction Prediction, which is to identify the specific chemical reaction catalyzed by a given enzyme. This involves understanding the enzyme's function based on its amino acid sequence and then selecting the correct transformation of substrates into products from a list of possible reactions.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact 502-aa sequence matches the UniProt entry for Crithidia fasciculata nucleoside transporter 2. That entry annotates inosine transport and cites experimental evidence from two publications, supporting choice B for this sequence. The cited papers were not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C3](#evidence-c3), [C4](#evidence-c4), [C5](#evidence-c5), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is strongly hydrophobic and consistent with a multipass membrane transporter, which weighs against the soluble-enzyme reactions in A and D. That does not distinguish inosine transport in B from magnesium transport in C.


**Missing item-specific fact**

> The protein's specific transported substrate—inosine—requires protein-specific functional annotation or experimental evidence absent from the input.


**Reason**

> General sequence features suggest membrane transport, but do not establish this transporter's substrate specificity; identifying the exact sequence or recalling its database entry would be lookup or memorization, not reasoning from the supplied evidence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer-only evidence supports B; it does not support another listed choice. The sequence alone, however, does not resolve the distinction between B and another transport reaction such as C.


### Important caveats

- Choice B describes translocation, not a conventional chemical transformation, so the task's label “Enzymatic Reaction Prediction” is imprecise.
- The database annotation cites experimental evidence, but the underlying papers were not independently validated here; the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and consistent with a multipass membrane transporter, which weighs against the soluble-enzyme reactions in A and D. That does not distinguish inosine transport in B from magnesium transport in C.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's specific transported substrate—inosine—requires protein-specific functional annotation or experimental evidence absent from the input.",
    "reason": "General sequence features suggest membrane transport, but do not establish this transporter's substrate specificity; identifying the exact sequence or recalling its database entry would be lookup or memorization, not reasoning from the supplied evidence."
  },
  "case_id": "catalytic_activity_0144",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C3",
      "C4",
      "C5",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The exact 502-aa sequence matches the UniProt entry for Crithidia fasciculata nucleoside transporter 2. That entry annotates inosine transport and cites experimental evidence from two publications, supporting choice B for this sequence. The cited papers were not independently reviewed here."
  },
  "important_caveats": [
    "Choice B describes translocation, not a conventional chemical transformation, so the task's label “Enzymatic Reaction Prediction” is imprecise.",
    "The database annotation cites experimental evidence, but the underlying papers were not independently validated here; the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer-only evidence supports B; it does not support another listed choice. The sequence alone, however, does not resolve the distinction between B and another transport reaction such as C."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "catalytic_activity_0144",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact 502-aa sequence matches the UniProt entry for Crithidia fasciculata nucleoside transporter 2. That entry annotates inosine transport and cites experimental evidence from two publications, supporting choice B for this sequence. The cited papers were not independently reviewed here.",
    "evidence_ids": ["C1", "C3", "C4", "C5", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and consistent with a multipass membrane transporter, which weighs against the soluble-enzyme reactions in A and D. That does not distinguish inosine transport in B from magnesium transport in C.",
    "missing_item_specific_fact": "The protein's specific transported substrate—inosine—requires protein-specific functional annotation or experimental evidence absent from the input.",
    "reason": "General sequence features suggest membrane transport, but do not establish this transporter's substrate specificity; identifying the exact sequence or recalling its database entry would be lookup or memorization, not reasoning from the supplied evidence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer-only evidence supports B; it does not support another listed choice. The sequence alone, however, does not resolve the distinction between B and another transport reaction such as C."
  },
  "important_caveats": [
    "Choice B describes translocation, not a conventional chemical transformation, so the task's label “Enzymatic Reaction Prediction” is imprecise.",
    "The database annotation cites experimental evidence, but the underlying papers were not independently validated here; the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry Q9GTP4 (NT2_CRIFA, Nucleoside transporter 2 / CfNT2 from Crithidia fasciculata) explicitly lists 'inosine(in) = inosine(out)' as a CATALYTIC ACTIVITY with experimental evidence codes ECO:0000269 (inferred from direct assay) from PubMed:15694482 and PubMed:20037157. The sequence matches exactly (502 AA, SHA256 match). The annotation is experimentally supported, not merely computational.

Citations as saved: [C5](#evidence-c5), [H5](#evidence-h5), [C1](#evidence-c1), [C4](#evidence-c4), [C7](#evidence-c7), [C8](#evidence-c8).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence encodes a polytopic membrane protein with approximately 11 transmembrane helices (readily identifiable from the long hydrophobic stretches). Among the four choices: (D) alcohol dehydrogenase is a soluble cytoplasmic enzyme with no TM domains — ruled out; (A) lipid A phosphoethanolamine transferase (EptA-type) is a single-pass membrane protein with a large cytoplasmic catalytic domain — inconsistent with 11 TM domains; (C) Mg2+ transporters of the well-characterized CorA (2 TM) and MgtE (5 TM) families have far fewer TM domains — inconsistent. The 11-TM topology with characteristic motifs (e.g., the 'GTLG' motif near the C-terminal region, N-terminal 'NANTFY' segment) is the hallmark of the Equilibrative Nucleoside Transporter (ENT) family, whose defining function is equilibrative nucleoside translocation (e.g., inosine transport). Thus the topology and motif pattern provide a concrete biological argument favoring B over A, C, and D.


**Missing item-specific fact**

> None essential. While precise substrate specificity (inosine vs. guanosine vs. adenosine) within the ENT family would require experimental data, the question only requires distinguishing a nucleoside transporter from an ion transporter, a lipid-modifying enzyme, and a dehydrogenase — a distinction achievable from topology and family-level motifs.


**Reason**

> A biologist familiar with membrane protein topology can count ~11 TM helices from the hydrophobicity pattern and match this to the ENT family architecture, thereby eliminating the single-pass (A), low-TM (C), and soluble (D) alternatives. This constitutes a concrete, general biological argument rather than a protein-specific database lookup.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Although the UniProt entry also lists guanosine transport as a catalytic activity, this is not among the four choices. Among A–D, only B is consistent with the protein's topology and family assignment. No ambiguity among the provided options.


### Important caveats

- The UniProt annotation for inosine transport is experimentally supported (ECO:0000269, direct assay), not merely inferred by similarity.
- The 11-TM topology argument requires familiarity with ENT family architecture; a model without this knowledge would struggle, but this is general membrane-protein biology, not a protein-specific lookup.
- The reviewer-only evidence confirms the annotation but was not available to the evaluated model; the reasoning argument stands independently from the sequence data.
- The historical UniProt record (entry version 55, first released 2026-01-28) post-dates the original sequence submission (2001-03-01); the author's source snapshot is unknown, but the sequence itself has been unchanged since 2001.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence encodes a polytopic membrane protein with approximately 11 transmembrane helices (readily identifiable from the long hydrophobic stretches). Among the four choices: (D) alcohol dehydrogenase is a soluble cytoplasmic enzyme with no TM domains — ruled out; (A) lipid A phosphoethanolamine transferase (EptA-type) is a single-pass membrane protein with a large cytoplasmic catalytic domain — inconsistent with 11 TM domains; (C) Mg2+ transporters of the well-characterized CorA (2 TM) and MgtE (5 TM) families have far fewer TM domains — inconsistent. The 11-TM topology with characteristic motifs (e.g., the 'GTLG' motif near the C-terminal region, N-terminal 'NANTFY' segment) is the hallmark of the Equilibrative Nucleoside Transporter (ENT) family, whose defining function is equilibrative nucleoside translocation (e.g., inosine transport). Thus the topology and motif pattern provide a concrete biological argument favoring B over A, C, and D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None essential. While precise substrate specificity (inosine vs. guanosine vs. adenosine) within the ENT family would require experimental data, the question only requires distinguishing a nucleoside transporter from an ion transporter, a lipid-modifying enzyme, and a dehydrogenase — a distinction achievable from topology and family-level motifs.",
    "reason": "A biologist familiar with membrane protein topology can count ~11 TM helices from the hydrophobicity pattern and match this to the ENT family architecture, thereby eliminating the single-pass (A), low-TM (C), and soluble (D) alternatives. This constitutes a concrete, general biological argument rather than a protein-specific database lookup."
  },
  "case_id": "catalytic_activity_0144",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H5",
      "C1",
      "C4",
      "C7",
      "C8"
    ],
    "judgment": "supported",
    "reason": "UniProt entry Q9GTP4 (NT2_CRIFA, Nucleoside transporter 2 / CfNT2 from Crithidia fasciculata) explicitly lists 'inosine(in) = inosine(out)' as a CATALYTIC ACTIVITY with experimental evidence codes ECO:0000269 (inferred from direct assay) from PubMed:15694482 and PubMed:20037157. The sequence matches exactly (502 AA, SHA256 match). The annotation is experimentally supported, not merely computational."
  },
  "important_caveats": [
    "The UniProt annotation for inosine transport is experimentally supported (ECO:0000269, direct assay), not merely inferred by similarity.",
    "The 11-TM topology argument requires familiarity with ENT family architecture; a model without this knowledge would struggle, but this is general membrane-protein biology, not a protein-specific lookup.",
    "The reviewer-only evidence confirms the annotation but was not available to the evaluated model; the reasoning argument stands independently from the sequence data.",
    "The historical UniProt record (entry version 55, first released 2026-01-28) post-dates the original sequence submission (2001-03-01); the author's source snapshot is unknown, but the sequence itself has been unchanged since 2001."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Although the UniProt entry also lists guanosine transport as a catalytic activity, this is not among the four choices. Among A–D, only B is consistent with the protein's topology and family assignment. No ambiguity among the provided options."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "catalytic_activity_0144",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry Q9GTP4 (NT2_CRIFA, Nucleoside transporter 2 / CfNT2 from Crithidia fasciculata) explicitly lists 'inosine(in) = inosine(out)' as a CATALYTIC ACTIVITY with experimental evidence codes ECO:0000269 (inferred from direct assay) from PubMed:15694482 and PubMed:20037157. The sequence matches exactly (502 AA, SHA256 match). The annotation is experimentally supported, not merely computational.",
    "evidence_ids": ["C5", "H5", "C1", "C4", "C7", "C8"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence encodes a polytopic membrane protein with approximately 11 transmembrane helices (readily identifiable from the long hydrophobic stretches). Among the four choices: (D) alcohol dehydrogenase is a soluble cytoplasmic enzyme with no TM domains — ruled out; (A) lipid A phosphoethanolamine transferase (EptA-type) is a single-pass membrane protein with a large cytoplasmic catalytic domain — inconsistent with 11 TM domains; (C) Mg2+ transporters of the well-characterized CorA (2 TM) and MgtE (5 TM) families have far fewer TM domains — inconsistent. The 11-TM topology with characteristic motifs (e.g., the 'GTLG' motif near the C-terminal region, N-terminal 'NANTFY' segment) is the hallmark of the Equilibrative Nucleoside Transporter (ENT) family, whose defining function is equilibrative nucleoside translocation (e.g., inosine transport). Thus the topology and motif pattern provide a concrete biological argument favoring B over A, C, and D.",
    "missing_item_specific_fact": "None essential. While precise substrate specificity (inosine vs. guanosine vs. adenosine) within the ENT family would require experimental data, the question only requires distinguishing a nucleoside transporter from an ion transporter, a lipid-modifying enzyme, and a dehydrogenase — a distinction achievable from topology and family-level motifs.",
    "reason": "A biologist familiar with membrane protein topology can count ~11 TM helices from the hydrophobicity pattern and match this to the ENT family architecture, thereby eliminating the single-pass (A), low-TM (C), and soluble (D) alternatives. This constitutes a concrete, general biological argument rather than a protein-specific database lookup."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Although the UniProt entry also lists guanosine transport as a catalytic activity, this is not among the four choices. Among A–D, only B is consistent with the protein's topology and family assignment. No ambiguity among the provided options."
  },
  "important_caveats": [
    "The UniProt annotation for inosine transport is experimentally supported (ECO:0000269, direct assay), not merely inferred by similarity.",
    "The 11-TM topology argument requires familiarity with ENT family architecture; a model without this knowledge would struggle, but this is general membrane-protein biology, not a protein-specific lookup.",
    "The reviewer-only evidence confirms the annotation but was not available to the evaluated model; the reasoning argument stands independently from the sequence data.",
    "The historical UniProt record (entry version 55, first released 2026-01-28) post-dates the original sequence submission (2001-03-01); the author's source snapshot is unknown, but the sequence itself has been unchanged since 2001."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched entry records inosine transport as the reaction, with experimental evidence cited (ECO:0000269). This supports choice B for the supplied protein.

Citations as saved: [C5](#evidence-c5), [H5](#evidence-h5).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The roughly 500-residue sequence has the many-transmembrane-helix architecture and sequence pattern characteristic of equilibrative nucleoside transporter family proteins. Transferable knowledge of that family supports nucleoside translocation, making B a meaningful fit; the other choices describe magnesium transport or chemically transforming enzyme reactions.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Family-level recognition provides a credible distinction among these options without needing the exact protein's recorded answer. Sequence alone may not establish inosine as a substrate with certainty, but B is supported by the family inference and the offered alternatives.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The options present distinct reaction types, and the sequence supports a nucleoside transporter rather than the alternatives.


### Important caveats

- The evidence supports this specific substrate annotation experimentally, while the transferable inference from the sequence identifies the transporter family more readily than it proves inosine specificity.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The roughly 500-residue sequence has the many-transmembrane-helix architecture and sequence pattern characteristic of equilibrative nucleoside transporter family proteins. Transferable knowledge of that family supports nucleoside translocation, making B a meaningful fit; the other choices describe magnesium transport or chemically transforming enzyme reactions.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Family-level recognition provides a credible distinction among these options without needing the exact protein's recorded answer. Sequence alone may not establish inosine as a substrate with certainty, but B is supported by the family inference and the offered alternatives."
  },
  "case_id": "catalytic_activity_0144",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched entry records inosine transport as the reaction, with experimental evidence cited (ECO:0000269). This supports choice B for the supplied protein."
  },
  "important_caveats": [
    "The evidence supports this specific substrate annotation experimentally, while the transferable inference from the sequence identifies the transporter family more readily than it proves inosine specificity."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The options present distinct reaction types, and the sequence supports a nucleoside transporter rather than the alternatives."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "catalytic_activity_0144",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched entry records inosine transport as the reaction, with experimental evidence cited (ECO:0000269). This supports choice B for the supplied protein.",
    "evidence_ids": ["C5", "H5"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The roughly 500-residue sequence has the many-transmembrane-helix architecture and sequence pattern characteristic of equilibrative nucleoside transporter family proteins. Transferable knowledge of that family supports nucleoside translocation, making B a meaningful fit; the other choices describe magnesium transport or chemically transforming enzyme reactions.",
    "missing_item_specific_fact": "",
    "reason": "Family-level recognition provides a credible distinction among these options without needing the exact protein's recorded answer. Sequence alone may not establish inosine as a substrate with certainty, but B is supported by the family inference and the offered alternatives."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The options present distinct reaction types, and the sequence supports a nucleoside transporter rather than the alternatives."
  },
  "important_caveats": [
    "The evidence supports this specific substrate annotation experimentally, while the transferable inference from the sequence identifies the transporter family more readily than it proves inosine specificity."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry Q9GTP4 (NT2_CRIFA, Crithidia fasciculata) explicitly annotates 'inosine(in) = inosine(out)' as a catalytic/transporter activity with direct experimental evidence (ECO:0000269, PubMed:15694482 and PubMed:20037157). The protein is named 'Nucleoside transporter 2' / 'Equilibrative nucleoside transporter 2.' The sequence in the question matches the canonical entry exactly (502 aa, SHA256 confirmed). The evidence is experimental, not merely computational inference.

Citations as saved: [C5](#evidence-c5), [H5](#evidence-h5).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 502-aa sequence exhibits a highly hydrophobic, multi-pass transmembrane architecture with approximately 11 transmembrane helical segments and an N-terminal signal peptide, which is the hallmark topology of the equilibrative nucleoside transporter (ENT/SLC29) family. This architecture immediately eliminates: (D) alcohol dehydrogenase, which is a ~350-aa soluble enzyme with a Rossmann-fold NAD-binding domain (GxGxG motif) and no TM segments; (A) lipid A phosphotransferase, which is a membrane-associated but not multi-pass TM enzyme with catalytic His/Asp residues for phosphotransfer; and (C) Mg(2+) transporters such as CorA (4 TM + large cytoplasmic domain) or MgtE (5 TM + CBS domains), whose topologies are fundamentally different from the 11-TM pattern seen here. Among the remaining transporter options, the equilibrative (passive, no ATP/proton coupling) format 'substrate(in) = substrate(out)' matches the ENT family mechanism. Within ENT transporters, purine nucleosides like inosine are canonical substrates. The sequence also contains a region (~residues 138-172) consistent with TM4, which in ENT family members forms part of the nucleoside-binding pocket. This is a family-level topological and mechanistic inference transferable from well-characterized ENT homologs.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The multi-pass TM topology (~11 helices), signal peptide, and equilibrative transport format are directly readable from the sequence and match the ENT family. Distinguishing ENT from Mg transporters (CorA/MgtE) and from soluble enzymes (ADH, lipid A phosphotransferase) is achievable through standard family-level topology knowledge without needing the specific UniProt annotation of this exact protein.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options represent fundamentally different protein classes (lipid A phosphotransferase, nucleoside transporter, Mg transporter, alcohol dehydrogenase) with distinct architectures and mechanisms. The sequence's 11-TM membrane topology and equilibrative format uniquely point to B. No other option is architecturally or mechanistically plausible for this sequence.


### Important caveats

- The UniProt entry also lists 'guanosine(in) = guanosine(out)' as a catalytic activity, but guanosine transport is not among the offered choices, so this does not create ambiguity within the given options.
- The protein is from Crithidia fasciculata (a trypanosomatid), an organism not explicitly stated in the question; however, the ENT family topology is conserved across eukaryotes and the reasoning does not depend on knowing the organism.
- The sequence was annotated in 2025 (Swiss-Prot integration) based on 2005 and 2010 experimental papers; the evidence codes (ECO:0000269) indicate direct experimental assay evidence, not computational prediction.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 502-aa sequence exhibits a highly hydrophobic, multi-pass transmembrane architecture with approximately 11 transmembrane helical segments and an N-terminal signal peptide, which is the hallmark topology of the equilibrative nucleoside transporter (ENT/SLC29) family. This architecture immediately eliminates: (D) alcohol dehydrogenase, which is a ~350-aa soluble enzyme with a Rossmann-fold NAD-binding domain (GxGxG motif) and no TM segments; (A) lipid A phosphotransferase, which is a membrane-associated but not multi-pass TM enzyme with catalytic His/Asp residues for phosphotransfer; and (C) Mg(2+) transporters such as CorA (4 TM + large cytoplasmic domain) or MgtE (5 TM + CBS domains), whose topologies are fundamentally different from the 11-TM pattern seen here. Among the remaining transporter options, the equilibrative (passive, no ATP/proton coupling) format 'substrate(in) = substrate(out)' matches the ENT family mechanism. Within ENT transporters, purine nucleosides like inosine are canonical substrates. The sequence also contains a region (~residues 138-172) consistent with TM4, which in ENT family members forms part of the nucleoside-binding pocket. This is a family-level topological and mechanistic inference transferable from well-characterized ENT homologs.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The multi-pass TM topology (~11 helices), signal peptide, and equilibrative transport format are directly readable from the sequence and match the ENT family. Distinguishing ENT from Mg transporters (CorA/MgtE) and from soluble enzymes (ADH, lipid A phosphotransferase) is achievable through standard family-level topology knowledge without needing the specific UniProt annotation of this exact protein."
  },
  "case_id": "catalytic_activity_0144",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry Q9GTP4 (NT2_CRIFA, Crithidia fasciculata) explicitly annotates 'inosine(in) = inosine(out)' as a catalytic/transporter activity with direct experimental evidence (ECO:0000269, PubMed:15694482 and PubMed:20037157). The protein is named 'Nucleoside transporter 2' / 'Equilibrative nucleoside transporter 2.' The sequence in the question matches the canonical entry exactly (502 aa, SHA256 confirmed). The evidence is experimental, not merely computational inference."
  },
  "important_caveats": [
    "The UniProt entry also lists 'guanosine(in) = guanosine(out)' as a catalytic activity, but guanosine transport is not among the offered choices, so this does not create ambiguity within the given options.",
    "The protein is from Crithidia fasciculata (a trypanosomatid), an organism not explicitly stated in the question; however, the ENT family topology is conserved across eukaryotes and the reasoning does not depend on knowing the organism.",
    "The sequence was annotated in 2025 (Swiss-Prot integration) based on 2005 and 2010 experimental papers; the evidence codes (ECO:0000269) indicate direct experimental assay evidence, not computational prediction."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent fundamentally different protein classes (lipid A phosphotransferase, nucleoside transporter, Mg transporter, alcohol dehydrogenase) with distinct architectures and mechanisms. The sequence's 11-TM membrane topology and equilibrative format uniquely point to B. No other option is architecturally or mechanistically plausible for this sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "catalytic_activity_0144",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry Q9GTP4 (NT2_CRIFA, Crithidia fasciculata) explicitly annotates 'inosine(in) = inosine(out)' as a catalytic/transporter activity with direct experimental evidence (ECO:0000269, PubMed:15694482 and PubMed:20037157). The protein is named 'Nucleoside transporter 2' / 'Equilibrative nucleoside transporter 2.' The sequence in the question matches the canonical entry exactly (502 aa, SHA256 confirmed). The evidence is experimental, not merely computational inference.",
    "evidence_ids": ["C5", "H5"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 502-aa sequence exhibits a highly hydrophobic, multi-pass transmembrane architecture with approximately 11 transmembrane helical segments and an N-terminal signal peptide, which is the hallmark topology of the equilibrative nucleoside transporter (ENT/SLC29) family. This architecture immediately eliminates: (D) alcohol dehydrogenase, which is a ~350-aa soluble enzyme with a Rossmann-fold NAD-binding domain (GxGxG motif) and no TM segments; (A) lipid A phosphotransferase, which is a membrane-associated but not multi-pass TM enzyme with catalytic His/Asp residues for phosphotransfer; and (C) Mg(2+) transporters such as CorA (4 TM + large cytoplasmic domain) or MgtE (5 TM + CBS domains), whose topologies are fundamentally different from the 11-TM pattern seen here. Among the remaining transporter options, the equilibrative (passive, no ATP/proton coupling) format 'substrate(in) = substrate(out)' matches the ENT family mechanism. Within ENT transporters, purine nucleosides like inosine are canonical substrates. The sequence also contains a region (~residues 138-172) consistent with TM4, which in ENT family members forms part of the nucleoside-binding pocket. This is a family-level topological and mechanistic inference transferable from well-characterized ENT homologs.",
    "missing_item_specific_fact": "",
    "reason": "The multi-pass TM topology (~11 helices), signal peptide, and equilibrative transport format are directly readable from the sequence and match the ENT family. Distinguishing ENT from Mg transporters (CorA/MgtE) and from soluble enzymes (ADH, lipid A phosphotransferase) is achievable through standard family-level topology knowledge without needing the specific UniProt annotation of this exact protein."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent fundamentally different protein classes (lipid A phosphotransferase, nucleoside transporter, Mg transporter, alcohol dehydrogenase) with distinct architectures and mechanisms. The sequence's 11-TM membrane topology and equilibrative format uniquely point to B. No other option is architecturally or mechanistically plausible for this sequence."
  },
  "important_caveats": [
    "The UniProt entry also lists 'guanosine(in) = guanosine(out)' as a catalytic activity, but guanosine transport is not among the offered choices, so this does not create ambiguity within the given options.",
    "The protein is from Crithidia fasciculata (a trypanosomatid), an organism not explicitly stated in the question; however, the ENT family topology is conserved across eukaryotes and the reasoning does not depend on knowing the organism.",
    "The sequence was annotated in 2025 (Swiss-Prot integration) based on 2005 and 2010 experimental papers; the evidence codes (ECO:0000269) indicate direct experimental assay evidence, not computational prediction."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "Q9GTP4",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "6e53d808d65dc861f251d0ee2f1b1ba4738fbf7c8abbca765447ebb335e58560",
  "benchmark_sequence_length": 502,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 55,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-01-28",
    "lastSequenceUpdateDate": "2001-03-01",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "current_source_sequence_sha256": "6e53d808d65dc861f251d0ee2f1b1ba4738fbf7c8abbca765447ebb335e58560",
  "current_source_sequence_length": 502,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 55,
  "selected_historical_version": {
    "accession": "Q9GTP4",
    "database": "Swiss-Prot",
    "entryVersion": 55,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "NT2_CRIFA",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "130ca0749d2c91bc4f41009fc3423401ec6f66d72dd1c0a97de44d68f33480c8",
  "selected_historical_source_sequence_sha256": "6e53d808d65dc861f251d0ee2f1b1ba4738fbf7c8abbca765447ebb335e58560",
  "selected_historical_source_sequence_length": 502,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 55,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9GTP4.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9GTP4.json",
  "source_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "retrieved_utc": "2026-11-02T04:32:48.296419+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"Q9GTP4\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9GTP4.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9GTP4.json",
  "source_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "retrieved_utc": "2026-11-02T04:32:48.296419+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":55,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-01-28\",\"lastSequenceUpdateDate\":\"2001-03-01\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9GTP4.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9GTP4.json",
  "source_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "retrieved_utc": "2026-11-02T04:32:48.296419+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"AAG22611.1\",\"source\":\"EMBL\"}],\"lineage\":[\"Eukaryota\",\"Discoba\",\"Euglenozoa\",\"Kinetoplastea\",\"Metakinetoplastina\",\"Trypanosomatida\",\"Trypanosomatidae\",\"Leishmaniinae\",\"Crithidia\"],\"scientificName\":\"Crithidia fasciculata\",\"taxonId\":5656}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9GTP4.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9GTP4.json",
  "source_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "retrieved_utc": "2026-11-02T04:32:48.296419+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"20037157\",\"source\":\"PubMed\"}],\"value\":\"Equilibrative nucleoside transporter 2\"}}],\"recommendedName\":{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"15694482\",\"source\":\"PubMed\"}],\"value\":\"Nucleoside transporter 2\"},\"shortNames\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"15694482\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000303\",\"id\":\"20037157\",\"source\":\"PubMed\"}],\"value\":\"CfNT2\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9GTP4.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9GTP4.json",
  "source_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "retrieved_utc": "2026-11-02T04:32:48.296419+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"CATALYTIC ACTIVITY\",\"reaction\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"15694482\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000269\",\"id\":\"20037157\",\"source\":\"PubMed\"}],\"name\":\"inosine(in) = inosine(out)\",\"reactionCrossReferences\":[{\"database\":\"Rhea\",\"id\":\"RHEA:75375\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:17596\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9GTP4.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9GTP4.json",
  "source_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "retrieved_utc": "2026-11-02T04:32:48.296419+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"CATALYTIC ACTIVITY\",\"reaction\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"15694482\",\"source\":\"PubMed\"}],\"name\":\"guanosine(in) = guanosine(out)\",\"reactionCrossReferences\":[{\"database\":\"Rhea\",\"id\":\"RHEA:75371\"},{\"database\":\"ChEBI\",\"id\":\"CHEBI:16750\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9GTP4.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9GTP4.json",
  "source_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "retrieved_utc": "2026-11-02T04:32:48.296419+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu W.\",\"Arendt C.S.\",\"Gessford S.K.\",\"Ntaba D.\",\"Carter N.S.\",\"Ullman B.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"15694482\"},{\"database\":\"DOI\",\"id\":\"10.1016/j.molbiopara.2004.11.018\"}],\"citationType\":\"journal article\",\"firstPage\":\"1\",\"id\":\"15694482\",\"journal\":\"Mol. Biochem. Parasitol.\",\"lastPage\":\"12\",\"publicationDate\":\"2005\",\"title\":\"Identification and characterization of purine nucleoside transporters from Crithidia fasciculata.\",\"volume\":\"140\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"TRANSPORTER ACTIVITY\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"INDUCTION\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9GTP4.json)

```json
{
  "evidence_id": "C8",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/Q9GTP4.json",
  "source_sha256": "3c9982e101acb399e2361c4884d826caa6e853175a76e749eee018234bb47b73",
  "retrieved_utc": "2026-11-02T04:32:48.296419+00:00",
  "json_pointer": "/references/2",
  "excerpt": "{\"citation\":{\"authors\":[\"Arendt C.S.\",\"Ullman B.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"20037157\"},{\"database\":\"DOI\",\"id\":\"10.1074/jbc.m109.074351\"}],\"citationType\":\"journal article\",\"firstPage\":\"6024\",\"id\":\"20037157\",\"journal\":\"J. Biol. Chem.\",\"lastPage\":\"6035\",\"publicationDate\":\"2010\",\"title\":\"Role of transmembrane domain 4 in ligand permeation by Crithidia fasciculata equilibrative nucleoside transporter 2 (CfNT2).\",\"volume\":\"285\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceNumber\":3,\"referencePositions\":[\"FUNCTION\",\"TRANSPORTER ACTIVITY\",\"SUBCELLULAR LOCATION\",\"MUTAGENESIS OF VAL-89; HIS-138; GLY-139; ALA-140; ILE-141; ALA-142; VAL-143; ILE-144; MET-145; VAL-146; VAL-147; ALA-148; VAL-150; GLY-151; GLY-152; PHE-153; SER-154; LYS-155; ALA-156; LEU-157; ASP-159; SER-160; THR-162; ASN-163; ALA-164; LEU-165; VAL-166; GLY-167; PRO-168; PHE-169; PRO-170; THR-171 AND LYS-172\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55",
  "source_sha256": "130ca0749d2c91bc4f41009fc3423401ec6f66d72dd1c0a97de44d68f33480c8",
  "retrieved_utc": "2026-11-02T04:32:52.675125+00:00",
  "source_locator": "lines 1-12",
  "excerpt": "ID   NT2_CRIFA               Reviewed;         502 AA.\nAC   Q9GTP4;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   01-MAR-2001, sequence version 1.\nDT   28-JAN-2026, entry version 55.\nDE   RecName: Full=Nucleoside transporter 2 {ECO:0000303|PubMed:15694482};\nDE            Short=CfNT2 {ECO:0000303|PubMed:15694482, ECO:0000303|PubMed:20037157};\nDE   AltName: Full=Equilibrative nucleoside transporter 2 {ECO:0000303|PubMed:20037157};\nOS   Crithidia fasciculata.\nOC   Eukaryota; Discoba; Euglenozoa; Kinetoplastea; Metakinetoplastina;\nOC   Trypanosomatida; Trypanosomatidae; Leishmaniinae; Crithidia.\nOX   NCBI_TaxID=5656 {ECO:0000312|EMBL:AAG22611.1};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 55,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55",
  "source_sha256": "130ca0749d2c91bc4f41009fc3423401ec6f66d72dd1c0a97de44d68f33480c8",
  "retrieved_utc": "2026-11-02T04:32:52.675125+00:00",
  "source_locator": "lines 6-8",
  "excerpt": "DE   RecName: Full=Nucleoside transporter 2 {ECO:0000303|PubMed:15694482};\nDE            Short=CfNT2 {ECO:0000303|PubMed:15694482, ECO:0000303|PubMed:20037157};\nDE   AltName: Full=Equilibrative nucleoside transporter 2 {ECO:0000303|PubMed:20037157};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 55,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55",
  "source_sha256": "130ca0749d2c91bc4f41009fc3423401ec6f66d72dd1c0a97de44d68f33480c8",
  "retrieved_utc": "2026-11-02T04:32:52.675125+00:00",
  "source_locator": "lines 19-26",
  "excerpt": "RN   [2] {ECO:0000305}\nRP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND\nRP   INDUCTION.\nRX   PubMed=15694482; DOI=10.1016/j.molbiopara.2004.11.018;\nRA   Liu W., Arendt C.S., Gessford S.K., Ntaba D., Carter N.S., Ullman B.;\nRT   \"Identification and characterization of purine nucleoside transporters from\nRT   Crithidia fasciculata.\";\nRL   Mol. Biochem. Parasitol. 140:1-12(2005).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 55,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55",
  "source_sha256": "130ca0749d2c91bc4f41009fc3423401ec6f66d72dd1c0a97de44d68f33480c8",
  "retrieved_utc": "2026-11-02T04:32:52.675125+00:00",
  "source_locator": "lines 27-38",
  "excerpt": "RN   [3] {ECO:0000305}\nRP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF\nRP   VAL-89; HIS-138; GLY-139; ALA-140; ILE-141; ALA-142; VAL-143; ILE-144;\nRP   MET-145; VAL-146; VAL-147; ALA-148; VAL-150; GLY-151; GLY-152; PHE-153;\nRP   SER-154; LYS-155; ALA-156; LEU-157; ASP-159; SER-160; THR-162; ASN-163;\nRP   ALA-164; LEU-165; VAL-166; GLY-167; PRO-168; PHE-169; PRO-170; THR-171 AND\nRP   LYS-172.\nRX   PubMed=20037157; DOI=10.1074/jbc.m109.074351;\nRA   Arendt C.S., Ullman B.;\nRT   \"Role of transmembrane domain 4 in ligand permeation by Crithidia\nRT   fasciculata equilibrative nucleoside transporter 2 (CfNT2).\";\nRL   J. Biol. Chem. 285:6024-6035(2010).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 55,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55",
  "source_sha256": "130ca0749d2c91bc4f41009fc3423401ec6f66d72dd1c0a97de44d68f33480c8",
  "retrieved_utc": "2026-11-02T04:32:52.675125+00:00",
  "source_locator": "lines 41-44",
  "excerpt": "CC   -!- CATALYTIC ACTIVITY:\nCC       Reaction=inosine(in) = inosine(out); Xref=Rhea:RHEA:75375,\nCC         ChEBI:CHEBI:17596; Evidence={ECO:0000269|PubMed:15694482,\nCC         ECO:0000269|PubMed:20037157};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 55,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55)

```json
{
  "evidence_id": "H6",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/Q9GTP4?format=txt&versions=55",
  "source_sha256": "130ca0749d2c91bc4f41009fc3423401ec6f66d72dd1c0a97de44d68f33480c8",
  "retrieved_utc": "2026-11-02T04:32:52.675125+00:00",
  "source_locator": "lines 45-47",
  "excerpt": "CC   -!- CATALYTIC ACTIVITY:\nCC       Reaction=guanosine(in) = guanosine(out); Xref=Rhea:RHEA:75371,\nCC         ChEBI:CHEBI:16750; Evidence={ECO:0000269|PubMed:15694482};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 55,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/catalytic_activity.json), zero-based source row 144. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
